Pull-down assays followed by western blot analysis revealed significant ubiquitination of EIF3b in the PUS1-knockdown group, whereas in PUS1-overexpressing tumor cells, EIF3b exhibited markedly reduced polyubiquitination (Fig. 5H&I). The gene discussed is PUS1; the disease is neoplasm.